NCT03753932 (IMFDHAC) is a NA clinical trial of Fixed prosthodontics in Head and Neck Neoplasms, sponsored by Region Jönköping County.

Who is sponsoring NCT03753932?

NCT03753932 is sponsored by Region Jönköping County.

What drugs are being tested in NCT03753932?

Interventions in NCT03753932: Fixed prosthodontics.

What condition does NCT03753932 study?

NCT03753932 studies Head and Neck Neoplasms, Dental Prosthesis, Dentures, Quality of Life.

Is NCT03753932 still recruiting?

NCT03753932 is currently completed. Last updated 19 May 2022.

Last reviewed 2022-05-19 · How we verify

NCT03753932: IMFDHAC

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Impact of Fixed Dentures in Head and Neck Cancer (IMFDHAC)

Completed NA Last updated 19 May 2022

What this trial tests

NA trial testing Fixed prosthodontics in Head and Neck Neoplasms in 64 participants. Completed in 17 September 2021.

Timeline

1 March 2013

Primary endpoint
17 September 2021

17 September 2021

Quick facts

Lead sponsor	Region Jönköping County
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	treatment
Enrollment	64
Start date	1 March 2013
Primary completion	17 September 2021
Estimated completion	17 September 2021
Sites	1 location across Sweden

Drugs / interventions tested

Fixed prosthodontics

Conditions studied

Head and Neck Neoplasms — all drugs for Head and Neck Neoplasms →
Dental Prosthesis — all drugs for Dental Prosthesis →
Dentures — all drugs for Dentures →
Quality of Life — all drugs for Quality of Life →

Sponsor

Region Jönköping County — full company profile →

Who can join

Eligibility, any sex, with Head and Neck Neoplasms or Dental Prosthesis. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of the multi centre study is to evaluate an intervention, which means that patients undergoing radiotherapy for head and neck cancer will receive fixed dentures in accordance with the Public Health Care fee system with regard to well-being and oral health related quality of life. Hypotheses: the intervention will improve oral health related quality of life, general wellbeing, and nutrition in patients treated by radiotherapy, with or without combination of chemotherapy or surgery against head and neck cancer.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Head and Neck Neoplasms

Currently open trials in the same condition.

NCT07491536 — Ozone Therapy With Biomimetic Oral Care for Cancer-Related Oral Mucositis · NA · recruiting
NCT06912087 — Dose Finding Study of Zanzalintinib With Pembrolizumab and Cetuximab in Head and Neck SCC · Phase 1 · recruiting
NCT06998069 — Head and Neck Cancer Study Project in the Geriatric Population · Phase 3 · recruiting
NCT07158164 — DPYD Pharmacogenomics and Fluoropyrimidine (FP) Dose-Adjustment · Phase 4 · recruiting
NCT06303180 — NIDCD Otolaryngology Clinical Protocol Biospecimen Bank · recruiting

Other Region Jönköping County trials

Trials by the same sponsor.

NCT07273357 — Aspects of Adjuvant CDK4/6 Inhibitors in Older Breast Cancer Patients - Focusing on Geriatric Screening · not yet recruiting
NCT07244250 — The Present Study Aims to Follow up on All Root Canal Treatments Performed During the Year 2023 Within the Public Dental · not yet recruiting
NCT06719869 — Central Venous Catheter vs Midline in Difficulty Access Patient - Pilot Trial · NA · completed
NCT05688384 — Patient-Controlled Sedation in Port Implantation (PACSPI-2) · Phase 4 · completed
NCT06016140 — A Medication Plan for Safer Medication Treatment in Older Persons · NA · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03753932 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Region Jönköping County
Last refreshed: 19 May 2022

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03753932.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing